Ken Fisher's ACAD Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 732,872 shares of ACADIA Pharmaceuticals Inc. (ACAD) worth $16.31 M, representing 0.01% of the portfolio. First purchased in 2023-Q4, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in ACAD, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 328,181 shares. Largest reduction occurred in Q2 2025, reducing 44,710 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's ACADIA Pharmaceuticals (ACAD) Holding Value Over Time
Track share changes against reported price movement
Quarterly ACADIA Pharmaceuticals (ACAD) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +67,785 | Add 10.19% | 732,872 | $22.26 |
| Q4 2025 | +26,595 | Add 4.17% | 665,087 | $26.71 |
| Q3 2025 | +328,181 | Add 105.76% | 638,492 | $21.34 |
| Q2 2025 | -44,710 | Reduce 12.59% | 310,311 | $21.57 |
| Q1 2025 | +27,516 | Add 8.40% | 355,021 | $16.61 |
| Q4 2024 | +132,906 | Add 68.30% | 327,505 | $18.35 |
| Q3 2024 | +31,980 | Add 19.67% | 194,599 | $15.38 |
| Q2 2024 | +9,689 | Add 6.34% | 162,619 | $16.25 |
| Q1 2024 | +9,876 | Add 6.90% | 152,930 | $18.49 |
| Q4 2023 | +143,054 | New Buy | 143,054 | $31.31 |
Ken Fisher's ACADIA Pharmaceuticals Investment FAQs
Ken Fisher first purchased ACADIA Pharmaceuticals Inc. (ACAD) in Q4 2023, acquiring 143,054 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held ACADIA Pharmaceuticals Inc. (ACAD) for 10 quarters since Q4 2023.
Ken Fisher's largest addition to ACADIA Pharmaceuticals Inc. (ACAD) was in Q3 2025, adding 638,492 shares worth $13.63 M.
According to the latest 13F filing for Q1 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 732,872 shares of ACADIA Pharmaceuticals Inc. (ACAD), valued at approximately $16.31 M.
As of the Q1 2026 filing, ACADIA Pharmaceuticals Inc. (ACAD) represents approximately 0.01% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in ACADIA Pharmaceuticals Inc. (ACAD) was 732,872 shares, as reported at the end of Q1 2026.